RGLBX | RWICX | RGLBX / RWICX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 5 years | 23 years | - |
Gain YTD | 1.907 | 2.047 | 93% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 250 | 100% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 15.3B | 127B | 12% |
Annual Yield % from dividends | 0.73 | 1.43 | 51% |
Returns for 1 year | 12.75 | 10.57 | 121% |
Returns for 3 years | 13.30 | 7.92 | 168% |
Returns for 5 years | 38.25 | 26.56 | 144% |
Returns for 10 years | N/A | 46.41 | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
EEMX | 32.48 | 0.23 | +0.73% |
SPDR® MSCI Em Mkts Fssl Ful Free RsrvETF | |||
SCHM | 28.82 | 0.12 | +0.42% |
Schwab US Mid-Cap ETF™ | |||
APRQ | 24.68 | 0.01 | +0.06% |
Innovator Premium Income 40 Bar ETF -Apr | |||
KIE | 57.29 | -0.08 | -0.14% |
SPDR® S&P Insurance ETF | |||
PBE | 67.68 | -0.16 | -0.24% |
Invesco Biotechnology & Genome ETF |